Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma

被引：1
|
作者：
Bron, Luc [1 ]
Romero, Pedro [2 ]
机构：
[1] CHU Vaudois, Serv ORL Chirurg Cervicofaciale, CH-1011 Lausanne, Switzerland
[2] Inst Ludwig Rech Canc Epalinges, Div Onco Immunol, Lausanne, Switzerland
来源：
BULLETIN DU CANCER | 2007年 / 94卷 / 09期
关键词：
head and neck; squamous cell carcinoma; immunotherapy;
D O I：
10.1684/bdc.2007.0426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the past decades, prognosis of head and neck squamous cell carcinoma (HNSCC) has not improved even though treatment has made substantial progress, Since the description of immune response against some cancers, antitumoral immunotherapy has been studied to be used as adjunctive treatment in various cancer types. This article review contributions made in the field of immunotherapy on HNSCC in the past few years, It appears that this approach may play an important role in the treatment of head and neck squamous cell carcinoma. Among various TAAs, cancer testis antigens family may be promising candidates for specific immune therapy in HNSCC. Ongoing studies will confirm whether expression CTAs generate an immune response in clinical vaccine trials.
引用
收藏
页码：793 / 797
页数：5
相关论文
共 50 条
  • [41] Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
    Meliante, Piero Giuseppe
    Zoccali, Federica
    de Vincentiis, Marco
    Ralli, Massimo
    Petrella, Carla
    Fiore, Marco
    Minni, Antonio
    Barbato, Christian
    DIAGNOSTICS, 2023, 13 (05)
  • [42] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
  • [43] Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
    Mei, Zi
    Huang, Junwen
    Qiao, Bin
    Lam, Alfred King-yin
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2020, 12 (01)
  • [44] Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
    Hsieh, Ching-Yun
    Lin, Ching-Chan
    Chang, Wei-Chao
    BIOMEDICINES, 2023, 11 (11)
  • [45] Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives
    Daste, Amaury
    Larroquette, Mathieu
    Gibson, Nyere
    Lasserre, Matthieu
    Domblides, Charlotte
    IMMUNOTHERAPY, 2024, 16 (03) : 187 - 197
  • [46] The potential of treatment with anti-SIRPalpha antibodies as immunotherapy for the head and neck squamous cell carcinoma
    Ueda, Takashi
    Murata, Yoji
    Matsumoto, Saki
    Tanaka, Daisuke
    Saito, Yasuyuki
    Kotani, Takenori
    Nibu, Kenichi
    Matozaki, Takashi
    CANCER SCIENCE, 2025, 116 : 494 - 494
  • [47] Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
    Faraji, Farhoud
    Cohen, Ezra E. W.
    Guo, Theresa W.
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) : 1353 - 1358
  • [48] Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach
    Merlano, Marco C.
    Denaro, Nerina
    Garrone, Ornella
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (03) : 203 - 209
  • [49] Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
    Buck, Gabriela
    Huguenin, Pia
    Stoeckli, Sandro J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (01): : 50 - 57
  • [50] TREATMENT OF NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    JESSE, RH
    FLETCHER, GH
    CANCER, 1977, 39 (02) : 868 - 872
12345